![Ole Thastrup](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ole Thastrup
Founder at
2CUREX AB
Ole Thastrup active positions
| Companies | Position | Start | End |
|---|---|---|---|
| 2CUREX AB | Chairman | 15/12/2024 | - |
| Founder | 31/12/2005 | - | |
| Investor Relations Contact | 31/12/2005 | - | |
| Director/Board Member | 31/12/2005 | 15/12/2024 | |
| Chief Executive Officer | 17/06/2024 | 15/12/2024 | |
| Chief Tech/Sci/R&D Officer | 31/01/2021 | 31/12/2023 | |
2cureX ApS
 2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer | Director/Board Member | 31/12/2005 | - |
| Chief Tech/Sci/R&D Officer | 31/12/2005 | - | |
| Founder | 31/12/2005 | - | |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - | - |
Ot311 ApS | Director/Board Member | - | - |
| Chief Executive Officer | - | - | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation and endowment | Corporate Officer/Principal | - | - |
Career history of Ole Thastrup
Former positions of Ole Thastrup
| Companies | Position | Start | End |
|---|---|---|---|
| CARLSBERG A/S | Corporate Officer/Principal | 31/12/2001 | 31/12/2005 |
Noapab Holdings A/S
 Noapab Holdings A/S Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and diagnostics products | Chief Tech/Sci/R&D Officer | - | - |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Corporate Officer/Principal | - | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - | - |
Statistics
International
| Denmark | 9 |
| United States | 2 |
Operational
| Corporate Officer/Principal | 5 |
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 3 |
Sectoral
| Health Technology | 4 |
| Consumer Non-Durables | 2 |
| Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 9 |
|---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Health Technology |
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Carlsberg A/S
 Carlsberg A/S Beverages: AlcoholicConsumer Non-Durables Produces and markets beers and soft drinks | Consumer Non-Durables |
Novo Nordisk Fonden
Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation and endowment | Miscellaneous |
Noapab Holdings A/S
Noapab Holdings A/S Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and diagnostics products | Commercial Services |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer | Health Technology |
2cureX AB
 2cureX AB Develops and supplies in vitro diagnostic (IVD) devices | |
Ot311 ApS |
- Stock Market
- Insiders
- Ole Thastrup
- Experience
